Entera Bio Ltd. (NASDAQ:ENTX) will hold its 2Q20 earnings conference call with the financial community on 20th August 2020 at 8:30 AM Eastern Time.
The conference call will be webcast live on Internet at edge.media-server.com/mmc/p/zbs5xewg
Alternatively, callers may dial the number(s) (855) 547-3865 Toll Free, (United States) or (409) 217-8787 Toll Number, and the passcode is 5243229
Earnings Expectation
Entera Bio Ltd. is expected to report second quarter earnings results, before market open, on Thursday 20th August 2020.
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The companys lead product includes the EB612, an oral parathyroid hormone product candidate that has completed a Phase IIa clinical trial for hypoparathyroidism. It is also developing EB613 that has completed Phase I clinical trials for the treatment of osteoporosis and non-union bone fractures; and other platform modules.
